Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl R Alving

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Vaccine|May 6, 2008
Modulation of immunoproteasome subunits by liposomal lipid ANicholas J Steers, Carl R Alving, Mangala Rao
Biochimica Et Biophysica Acta|December 17, 2014
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysateZoltan Beck, Gary R Matyas, Carl R Alving
Current Topics in Microbiology and Immunology|November 9, 2020
Liposome Formulations as Adjuvants for VaccinesMangala Rao, Kristina K Peachman, Carl R Alving
Frontiers in Immunology|February 10, 2023
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21Carl R Alving, Mangala Rao, Gary R Matyas
Methods in Enzymology|January 13, 2004
Oil-in-water liposomal emulsions for vaccine deliveryGary R Matyas, Jean M Muderhwa, Carl R Alving
Biochimica Et Biophysica Acta|February 5, 2002
Potentiation of liposome-induced complement activation by surface-bound albuminSandor Savay, Janos Szebeni, Lajos Baranyi, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten DensitiesOscar B Torres, Carl R Alving, Gary R Matyas
Expert Opinion on Drug Delivery|February 12, 2016
Liposomal adjuvants for human vaccinesCarl R Alving, Zoltan Beck, Gary R Matyas, et al.
Journal of Drug Targeting|August 8, 2008
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopesZoltan Beck, Nicos Karasavvas, Gary R Matyas, et al.
Biochimica Et Biophysica Acta|December 23, 2008
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1Gary R Matyas, Zoltan Beck, Nicos Karasavvas, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Vaccine|May 6, 2008
Modulation of immunoproteasome subunits by liposomal lipid ANicholas J Steers, Carl R Alving, Mangala Rao
Biochimica Et Biophysica Acta|December 17, 2014
Detection of liposomal cholesterol and monophosphoryl lipid A by QS-21 saponin and Limulus polyphemus amebocyte lysateZoltan Beck, Gary R Matyas, Carl R Alving
Current Topics in Microbiology and Immunology|November 9, 2020
Liposome Formulations as Adjuvants for VaccinesMangala Rao, Kristina K Peachman, Carl R Alving
Frontiers in Immunology|February 10, 2023
Similarities and differences of chemical compositions and physical and functional properties of adjuvant system 01 and army liposome formulation with QS21Carl R Alving, Mangala Rao, Gary R Matyas
Methods in Enzymology|January 13, 2004
Oil-in-water liposomal emulsions for vaccine deliveryGary R Matyas, Jean M Muderhwa, Carl R Alving
Biochimica Et Biophysica Acta|February 5, 2002
Potentiation of liposome-induced complement activation by surface-bound albuminSandor Savay, Janos Szebeni, Lajos Baranyi, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten DensitiesOscar B Torres, Carl R Alving, Gary R Matyas
Expert Opinion on Drug Delivery|February 12, 2016
Liposomal adjuvants for human vaccinesCarl R Alving, Zoltan Beck, Gary R Matyas, et al.
Journal of Drug Targeting|August 8, 2008
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopesZoltan Beck, Nicos Karasavvas, Gary R Matyas, et al.
Biochimica Et Biophysica Acta|December 23, 2008
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1Gary R Matyas, Zoltan Beck, Nicos Karasavvas, et al.
Pageof 11